7-130275176-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001869.3(CPA2):āc.514A>Gā(p.Ile172Val) variant causes a missense change. The variant allele was found at a frequency of 0.00317 in 1,614,110 control chromosomes in the GnomAD database, including 143 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.017 ( 72 hom., cov: 32)
Exomes š: 0.0017 ( 71 hom. )
Consequence
CPA2
NM_001869.3 missense
NM_001869.3 missense
Scores
2
16
Clinical Significance
Conservation
PhyloP100: 4.05
Genes affected
CPA2 (HGNC:2297): (carboxypeptidase A2) Three different forms of human pancreatic procarboxypeptidase A have been isolated. The encoded protein represents the A2 form, which is a monomeric protein with different biochemical properties from the A1 and A3 forms. The A2 form of pancreatic procarboxypeptidase acts on aromatic C-terminal residues and is a secreted protein. [provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0068415105).
BP6
Variant 7-130275176-A-G is Benign according to our data. Variant chr7-130275176-A-G is described in ClinVar as [Benign]. Clinvar id is 792089.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0574 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CPA2 | NM_001869.3 | c.514A>G | p.Ile172Val | missense_variant | 6/11 | ENST00000222481.9 | NP_001860.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CPA2 | ENST00000222481.9 | c.514A>G | p.Ile172Val | missense_variant | 6/11 | 1 | NM_001869.3 | ENSP00000222481.4 | ||
CPA2 | ENST00000416698.1 | n.*65A>G | non_coding_transcript_exon_variant | 7/8 | 5 | ENSP00000395582.1 | ||||
CPA2 | ENST00000487259.5 | n.529A>G | non_coding_transcript_exon_variant | 6/7 | 2 | |||||
CPA2 | ENST00000416698.1 | n.*65A>G | 3_prime_UTR_variant | 7/8 | 5 | ENSP00000395582.1 |
Frequencies
GnomAD3 genomes AF: 0.0171 AC: 2608AN: 152246Hom.: 72 Cov.: 32
GnomAD3 genomes
AF:
AC:
2608
AN:
152246
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00449 AC: 1130AN: 251466Hom.: 28 AF XY: 0.00325 AC XY: 442AN XY: 135908
GnomAD3 exomes
AF:
AC:
1130
AN:
251466
Hom.:
AF XY:
AC XY:
442
AN XY:
135908
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00171 AC: 2495AN: 1461746Hom.: 71 Cov.: 30 AF XY: 0.00144 AC XY: 1047AN XY: 727180
GnomAD4 exome
AF:
AC:
2495
AN:
1461746
Hom.:
Cov.:
30
AF XY:
AC XY:
1047
AN XY:
727180
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0172 AC: 2618AN: 152364Hom.: 72 Cov.: 32 AF XY: 0.0164 AC XY: 1224AN XY: 74506
GnomAD4 genome
AF:
AC:
2618
AN:
152364
Hom.:
Cov.:
32
AF XY:
AC XY:
1224
AN XY:
74506
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
265
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
672
Asia WGS
AF:
AC:
14
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 31, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
MutationTaster
Benign
D
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at